| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Freese A | |
| P2860 | cites work | GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 |
| Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo | Q28306009 | ||
| Evidence that neurons harbor latent herpes simplex virus | Q34108496 | ||
| Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease | Q34320662 | ||
| Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. | Q35374311 | ||
| Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes | Q35414099 | ||
| Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA | Q36284482 | ||
| Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector | Q36480190 | ||
| Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors | Q36708223 | ||
| The herpes simplex virus virion host shutoff function. | Q36831702 | ||
| Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes | Q37401979 | ||
| Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants | Q37518848 | ||
| Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase | Q37689072 | ||
| Targets for gene therapy of Parkinson's disease: growth factors, signal transduction, and promoters | Q39457334 | ||
| Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy | Q40525981 | ||
| Recent progress in immunoisolated cell therapy | Q40575713 | ||
| Gene transfer to brain using herpes simplex virus vectors | Q40753488 | ||
| Parkinson's disease: the case for novel treatment strategies | Q40902093 | ||
| Prospects for gene therapy in Parkinson's disease | Q41159915 | ||
| Tetrahydrobiopterin-dependent production of L-dopa in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: future use for intracerebral grafting | Q41197596 | ||
| Application of ex vivo gene therapy in the treatment of Parkinson's disease | Q41450683 | ||
| Long-term survival of autologous muscle grafts in rat brain | Q41910781 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons | Q43244050 | ||
| The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector | Q44397432 | ||
| Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector | Q44471123 | ||
| HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology | Q45111676 | ||
| Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy | Q45756222 | ||
| Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant | Q45854779 | ||
| Long-term correction of rat model of Parkinson's disease by gene therapy | Q45872237 | ||
| An adenovirus vector for gene transfer into neurons and glia in the brain | Q45874317 | ||
| Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors | Q45875094 | ||
| In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector | Q45889326 | ||
| Morphological and neurochemical features of cultured primary skin fibroblasts of Fischer 344 rats following striatal implantation | Q46012400 | ||
| Brain-derived neurotrophic factor prevents neuronal death in vivo | Q48122588 | ||
| A model system for in vivo gene transfer into the central nervous system using an adenoviral vector | Q48325479 | ||
| Intracerebral transplants of primary muscle cells: a potential 'platform' for transgene expression in the brain | Q48508816 | ||
| Neuron saving schemes | Q59051902 | ||
| Transfer of a foreign gene into the brain using adenovirus vectors | Q64377820 | ||
| Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease | Q64383353 | ||
| P433 | issue | 2 | |
| P921 | main subject | gene therapy | Q213901 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 537-548 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Restorative gene therapy approaches to Parkinson's disease | |
| P478 | volume | 83 |
| Q45872390 | Gene therapy and infection control: more light on the way. | cites work | P2860 |
Search more.